Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia ; volume:22 ; number:1 ; day:16 ; month:8 ; year:2022 ; pages:1-11 ; date:12.2022
BMC cancer ; 22, Heft 1 (16.8.2022), 1-11, 12.2022
- Urheber
-
Bai, Lu
Zhang, Yong-zhan
Yan, Chen-hua
Wang, Yu
Xu, Lan-ping
Zhang, Xiao-hui
Zhang, Le-ping
Huang, Xiao-jun
Cheng, Yi-fei
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-022-09978-3
- URN
-
urn:nbn:de:101:1-2022110322380377068948
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bai, Lu
- Zhang, Yong-zhan
- Yan, Chen-hua
- Wang, Yu
- Xu, Lan-ping
- Zhang, Xiao-hui
- Zhang, Le-ping
- Huang, Xiao-jun
- Cheng, Yi-fei
- SpringerLink (Online service)
Ähnliche Objekte (12)
The role of EZH2 in CDK6 bockade-mediated differentiation in MLL-rearranged acute myeloid leukaemia
Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML
RNA binding proteins in MLL-rearranged leukemia
The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia
Using genome editing to model MLL rearranged leukemias
Molecular pathogenesis of disease progression in MLL-rearranged AML
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML
Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia
The role of EZH2 in CDK6 bockade-mediated differentiation in MLL-rearranged acute myeloid leukaemia
Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML
RNA binding proteins in MLL-rearranged leukemia
The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia
Using genome editing to model MLL rearranged leukemias
Molecular pathogenesis of disease progression in MLL-rearranged AML
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML
Dysregulation of haematopoietic stem cell regulatory programs in acute myeloid leukaemia
The role of EZH2 in CDK6 bockade-mediated differentiation in MLL-rearranged acute myeloid leukaemia
Reversal of MYB-dependent suppression of MAFB expression overrides leukaemia phenotype in MLL-rearranged AML
RNA binding proteins in MLL-rearranged leukemia
The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia
Using genome editing to model MLL rearranged leukemias
Molecular pathogenesis of disease progression in MLL-rearranged AML
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML